How do I choose adjunctive products for eye health?
Shelf order follows the evidence with its population labels attached: the AREDS2 formula leads as the supplement world's one disease-modifying landmark — for diagnosed intermediate AMD, the diagnosis as the entry ticket; lutein/zeaxanthin carries the healthy-population shield (the macular armor built from the diet-gap arithmetic, delivered with fat); and omega-3 closes with the estate's second Null Card — DREAM and AREDS2's twin retirements of the aisle's most popular story, the product included to teach what an honest label looks like. All three sit behind the exam calendar, the emergency rules, and ophthalmology's spectacular treatment tier. The products below are educational examples — not medical recommendations.

by Various (AREDS2-formula) · AMD Progression Formula
The only supplement formula in ophthalmology with a disease-modifying RCT: in diagnosed INTERMEDIATE AMD, the AREDS nutrient formula reduced progression to advanced disease by roughly 25% over five years — a real, population-specific result our zinc page's timeline already carries. The honest boundaries: benefit demonstrated in intermediate/advanced AMD, NOT in early AMD or prevention; the formula is a unit, not a DIY stack (the 80 mg zinc exceeds the general chronic ceiling our zinc page teaches — an exception studied in this population and worth a physician conversation); and the current lutein-based version exists because the ORIGINAL formula's beta-carotene raised lung cancer risk in smokers — AREDS2's correction, and this page's formulation lesson. 🚨 Confirmed intermediate AMD is the entry requirement — the diagnosis, not the shelf, decides.

by NOW Foods · Macular Pigment Carotenoids

by Nordic Naturals · The Structural DHA Base — Honestly Nulled